Vagina Disease
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Origin SciencesUK - Cambridge
1 programQuantification of human DNA retrieved and DNA fragmentation profile.N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Origin SciencesQuantification of human DNA retrieved and DNA fragmentation profile.
UNION therapeuticsundefined
Clinical Trials (2)
Total enrollment: 1,045 patients across 2 trials
Feasibility of the Oricol™ Sampling Device to Retrieve Vagina Mucus (Wall) Samples for Genomic & Epigenetic Analysis.
Start: Jan 2024Est. completion: Jul 202445 patients
N/ACompleted
Baseline Study of Vaginal Microbiota in Healthy Chinses Female Population
Start: May 2021Est. completion: Jul 20221,000 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.